Sort   by:  
 Page size 
ProteomicsSulfisoxazole inhibits exosome secretion for potential breast cancer treatment
Inhibitors of the secretion of cancer exosomes, which promote cancer progression and metastasis, can not only accelerate exosome biology research but also offer therapeutic benefits for cancer patients. We identified sulfisoxazole (SFX) which inhibits exosome secretion from breast cancer cells. SFX,...
ORGANISM(S): Homo sapiens (Human) 
2019-11-13 | PXD012689 | Pride
Breast cancer Sulfisoxazole Exosome Lc-ms/ms 
MetabolomicsEcological adaptation and succession of human fecal microbial communities in an automated in vitro fermentation system
Longitudinal studies of gut microbiota following specific interventions are vital for understanding how they influence host health. However, robust longitudinal sampling of gut microbial communities is a major challenge, which can be addressed using in vitro fermenters hosting complex microbial comm...
2021-07-15 | MTBLS2531 | MetaboLights
UnknownLong-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study.
Not available
S-EPMC8980600 | biostudies-literature
UnknownLaparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: 5-Year Outcomes of the KLASS-02 Randomized Clinical Trial.
Not available
S-EPMC9301593 | biostudies-literature
UnknownAdiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.
Not available
S-EPMC6481269 | biostudies-literature
UnknownMeasurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study.
Not available
S-EPMC11578795 | biostudies-literature
Sort   by:  
 Page size